Morgan Stanley Has Lowered Expectations for Campbell's (NASDAQ:CPB) Stock Price

Key Points

• Morgan Stanley cut its price target on Campbell's from $28 to $27 and kept an "equal weight" rating, implying roughly a 7.8% upside from the stock's current price.
• Multiple firms have trimmed targets recently and the consensus across analysts is a Reduce rating (2 Buy, 14 Hold, 5 Sell) with an average price target of $31.47.
• CPB trades around $25.05 near its 12‑month low, the company issued FY2026 EPS guidance of 2.40–2.55 after a recent quarter that beat EPS estimates, and several corporate insiders have sold shares.

Campbell's (NASDAQ:CPB - Get Free Report) had its price target decreased by equities researchers at Morgan Stanley from $28.00 to $27.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Morgan Stanley's price objective would indicate a potential upside of 7.78% from the company's current price.

CPB has been the subject of several other reports. Wells Fargo & Company lowered their price objective on Campbell's from $30.00 to $28.00 and set an "equal weight" rating for the company in a research report on Tuesday. Royal Bank Of Canada lowered their target price on shares of Campbell's from $35.00 to $30.00 and set a "sector perform" rating for the company in a report on Wednesday, December 10th. Stephens reduced their price target on shares of Campbell's from $40.00 to $38.00 and set an "overweight" rating for the company in a research report on Monday, December 8th. Weiss Ratings downgraded Campbell's from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, January 5th. Finally, DA Davidson reissued a "neutral" rating and issued a $30.00 price objective on shares of Campbell's in a report on Thursday, December 11th. Two investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and five have assigned a Sell rating to the company's stock. According to MarketBeat.com, Campbell's currently has a consensus rating of "Reduce" and an average price target of $31.47.

Campbell's Stock Down 0.0%

NASDAQ:CPB traded down $0.01 during mid-day trading on Friday, hitting $25.05. The stock had a trading volume of 1,781,649 shares, compared to its average volume of 7,234,714. Campbell's has a twelve month low of $24.86 and a twelve month high of $43.85. The stock has a 50-day simple moving average of $27.27 and a two-hundred day simple moving average of $29.75. The company has a current ratio of 0.82, a quick ratio of 0.34 and a debt-to-equity ratio of 1.54. The company has a market capitalization of $7.47 billion, a PE ratio of 12.98, a PEG ratio of 8.82 and a beta of -0.03.

Campbell's (NASDAQ:CPB - Get Free Report) last announced its quarterly earnings data on Tuesday, December 9th. The company reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.73 by $0.04. The company had revenue of $2.68 billion for the quarter. Campbell's had a net margin of 5.69% and a return on equity of 21.84%. Campbell's's revenue was down 3.4% on a year-over-year basis. Campbell's has set its FY 2026 guidance at 2.400-2.550 EPS. On average, equities research analysts anticipate that Campbell's will post 3.15 EPS for the current year.

Insider Activity

In related news, EVP Charles A. Brawley III sold 11,550 shares of the stock in a transaction dated Tuesday, December 30th. The shares were sold at an average price of $28.14, for a total transaction of $325,017.00. Following the completion of the transaction, the executive vice president directly owned 43,777 shares of the company's stock, valued at $1,231,884.78. This represents a 20.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Anthony Sanzio sold 2,700 shares of Campbell's stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $26.51, for a total value of $71,577.00. Following the completion of the sale, the executive vice president directly owned 25,264 shares in the company, valued at $669,748.64. This represents a 9.66% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 19.78% of the company's stock.

Institutional Investors Weigh In On Campbell's

Institutional investors have recently made changes to their positions in the stock. Stance Capital LLC acquired a new stake in shares of Campbell's in the third quarter valued at about $27,000. SBI Securities Co. Ltd. lifted its position in shares of Campbell's by 66.8% during the 2nd quarter. SBI Securities Co. Ltd. now owns 961 shares of the company's stock valued at $29,000 after acquiring an additional 385 shares during the period. Flagship Harbor Advisors LLC purchased a new stake in shares of Campbell's during the 4th quarter worth approximately $29,000. Sittner & Nelson LLC acquired a new stake in shares of Campbell's in the 4th quarter worth approximately $29,000. Finally, Los Angeles Capital Management LLC purchased a new position in Campbell's in the 4th quarter valued at approximately $29,000. 52.35% of the stock is currently owned by hedge funds and other institutional investors.

About Campbell's

Campbell's NASDAQ: CPB is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell's has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company's brand portfolio includes Campbell's Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.